Concord Biotech Ltd. is proposing an Initial Public Offering (IPO) on the NSE & BSE platform under the Mainboard category.
Subscription opens 04 Aug 2023, closes 08 Aug 2023. Listing expected 16 Aug 2023. Apply via ASBA or UPI.
Concord Biotech Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 20 | ₹14,820 |
| Retail (Max) | 13 | 260 | ₹192,660 |
| sNII (Min) | 14 | 280 | ₹207,480 |
| bNII (Min) | 68 | 1,360 | ₹1,007,760 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |